Company intelligence / Profile preview

SOLS

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

SOLS was a healthcare technology and medical device company that developed a software platform and mobile application for designing and delivering customized orthotics and insoles. Its products included SOLSRx, a medical-grade 3D-printed orthotic, and ExoSOLS, a direct-to-consumer custom insole offering. The company combined computer vision, machine learning, and foot-scanning workflows to improve footwear fit and foot health. Founded in 2013 in New York, SOLS was acquired by Aetrex Worldwide in 2018, and its technology appears to have been integrated into Aetrex's broader foot-scanning and fit platform. The company was commercial-stage prior to acquisition rather than a drug-development biotech.

Therapeutic areas: Rheumatology
Modalities: DeviceNon-pharmacological therapy
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on SOLS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOLS.

Explore the full profile